Author pages are created from data sourced from our academic publisher partnerships and public sources.
Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar® in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial
- O. Tabatabaei-Malazy, Masumeh Norani, +6 authors B. Larijani
- Iranian journal of public health
- 29 August 2018
Background: Due to high cost and burden of osteoporosis, it is reasonable to focus on the reduction of fractures as the main goal of treatment. We compared the efficacy and safety of a new biosimilar… Expand